Melhores TrueBeam médicos - TOP-13 médicos

O Dr. Mustafa Solak é um oncologista médico especializado em cânceres de mama, testículo, ovário, pulmão, cabeça-pescoço e gastrointestinal. Ele se formou na Faculdade de Medicina da Universidade de Hacettepe. Completou sua residência no Hospital de Ensino e Pesquisa Sisli Etfal de Istambul. Em seguida, fez uma bolsa de especialização no Instituto de Câncer da Universidade de Hacettepe.

O Dr. Solak geriu muitos casos complexos de câncer. Ele contribuiu para avanços clínicos em centros respeitados, incluindo o MD Anderson Cancer Center da Universidade do Texas. Também trabalhou no Hospital de Treinamento de Hitit University Corum e no Hospital Medical Park. Sua experiência demonstra um forte compromisso com o cuidado e a pesquisa do câncer.

Dr. Ofer Merimsly é o melhor médico em sarcoma, linfoma e câncer de pulmão em Israel e no mundo. Também é especialista no tratamento cirúrgico Whipple para pacientes com câncer de pâncreas. Chefe do Centro Nacional para sarcomas ósseos e de tecidos moles do Centro Médico Tel Aviv Sourasky (Ichilov).

Especialidade:

• Tratamento de todos os tipos de câncer de pulmão e órgãos torácicos
• Tratamento de todos os tipos de sarcomas ósseos e de tecidos moles
• Tratamento de tumores estromais do trato gastrointestinal

Educação e especialização:

• Ensino superior em medicina, formado pela Faculdade de Medicina da Universidade Hebraica de Jerusalém, Israel
• Residência em Oncologia Geral e Radioterapia
• Treinamento em radioterapia e braquiterapia no New York Hospital, EUA
• Curso de atualização especial para o tratamento de tumores do esqueleto e tecidos moles, Paris, França

Membro:

• Presidente da Sociedade de Oncologistas e Radioterapeutas de Israel
• Sociedade Americana de Câncer Científico
• Organização médica científica europeia
• Sociedade Europeia de Oncologia do sistema musculoesquelético
• Sociedade Internacional para o tratamento de tumores do tecido conjuntivo

Education and Specialization

• 2006: Kocaeli University Faculty of Medicine
• 2014: Akdeniz University Faculty of Medicine, Internal Medicine
• 2018: Akdeniz University Faculty of Medicine, Medical Oncology

Experience

• 2006 - 2008: Konya Derebucak District Hospital
• 2009 - 2015: Akdeniz University Hospital
• 2015: Antalya Kaş State Hospital
• 2015 - 2016: İnönü University Faculty of Medicine
• 2016 - 2021: Akdeniz University Hospital
• 2021 - 2023: Antalya Training and Research Hospital

Professor Ari Rafael — diretor do serviço de oncologia translacional e pesquisador do departamento de estudos clínicos de câncer no Centro Médico Sourasky (Ichilov, Tel Aviv). Os pacientes valorizam sua abordagem individualizada e atenção às necessidades de cada um.

Qualificação e valor para os pacientes:

• Coordena a unidade de oncologia diurna e lidera projetos de medicina genômica nacional. Assim, garante acesso a pesquisas de ponta.

• Trabalhou como pesquisador principal e sub-investigador principal em diversos ensaios clínicos de fase I–III, incluindo injeções intratumorais de mRNA e medicamentos virais. Os pacientes participam de métodos inovadores de tratamento.

• Possui experiência internacional nos EUA e no Reino Unido— garante a aplicação de padrões globais e protocolos avançados.

• Membro de organizações internacionais (ESMO, IASLC, ISLB, ISCORT, Associação Médica de Israel). Utiliza padrões modernos de tratamento e participa de pesquisas globais.

• Regularmente aprimora suas qualificações e participa de treinamentos em padrões internacionais de prática clínica, incluindo ICH GCP R2, Diretrizes do Ministério da Saúde de Israel, bem como cursos atualizados sobre consentimento informado, gerenciamento de efeitos colaterais e segurança dos pacientes.

Os pacientes apreciam o professor Rafael por sua precisa seleção de regimes de tratamento, implementação de inovações e abordagem atenciosa, o que garante confiança e segurança em todas as etapas da terapia.

Director of Radiotherapy Institute Oncology Division

Education/Residency:

• Completed residency in general oncology and radiotherapy (radiation therapy) at Sheba Hospital, Tel Hashomer.
• During her work, she gained extensive experience in treating tumors of the female reproductive system and is currently a coordinator for the treatment of patients suffering from these diseases.
• Fellowship - Anderson Cancer Center, Houston, Texas - 2012-2014

Dr. Tatyana Rabin's research interests include:

Methods of destruction of malignant neoplasms by heating with the help of ultrasonic waves, research into the use of brachytherapy in the treatment of oncogynecological diseases,

study of the mechanisms of response at the molecular level of prostate tumor cells to radiotherapy;

clinical studies of oncomammology, oncopulmonology, ocular lymphoma.

Dr. Rabin is investigating the molecular mechanisms by which prostate cancer cells respond to radiation therapy. This research is being conducted in collaboration with the Weizmann Institute of Science.

In addition, Dr. Rabin has been involved in clinical research in the areas of breast cancer, lung cancer, and ocular lymphoma.

Dr. Rabin is currently coordinating a new and unique study at Sheba Hospital that is investigating a method of treating cancerous tumors using MRI-guided ultrasound waves. This method involves raising the tumor's temperature to a certain level and then destroying it.

Awards:

Dr. Tatyana Rabin was recognized as the best hospital employee for 2007.

Experience and participation in scientific research:

• Scientific research in the field of gynecological oncology
• Scientific research in the field of lung tumors
• Application of brachytherapy in oncogynecology
• SBRT techniques in the treatment of tumors of the respiratory system
• Study of molecular mechanisms of prostate tumor cell response to radiation therapy. This study was organized in collaboration with the laboratory of the H. Weizmann Institute.
• In addition, Dr. Rabin has been involved in clinical research in the areas of breast cancer, lung cancer, and ocular lymphoma.

Membership in medical societies :

• Israel Society of Oncology and Clinical Radiotherapy (ISCORT) American Society of Radiology and Oncology (ASTRO)
• Israel Association of Palliative Medicine

Education

• (2004 – 2011), Faculty of Medicine/ Inonu University/ Malatya, Turkiye
• (2011 – 2015), Department of Radiology/ Bagcilar Training and Research Hospital/ Istanbul, Turkiye

Career

• (2016 – 2020), Diagnostic and Interventional Radiologist/ Mus State Hospital/ Mus,Turkiye
• (2020 – 2022), Assistant Professor of Diagnostic and Interventional Radiology/ Sakarya University Training and Research Hospital/ Sakarya, Turkiye
• (2023 – 2024), Associate Professor of Diagnostic and Interventional Radiology /Sakarya University Training and Research Hospital/ Sakarya, Turkiye
• (2024 - Present), Associate Professor of Diagnostic and Interventional Radiology /Medipol University Hospital/ Istanbul, Turkiye

Dr. Raj Nagarkar is a leading Surgical Oncologist with 19 years of experience. He has performed over 50,000 cancer surgeries. His main focus areas are Breast and Thoracic Surgical Oncology. He is involved in more than 200 clinical trials and has contributed to many national and international publications.

Dr. Nagarkar trained in Surgical Oncology at Tata Memorial Hospital, Mumbai. He also holds an MRCS from the Royal College of Surgeons, Edinburgh. He teaches DNB Superspecialty Surgical Oncology and Breast Surgery at Maharashtra University of Health Sciences. Dr. Nagarkar is dedicated to improving the quality of life for his patients.

Dr. Lalit Banswal is an experienced oncological surgeon with 10 years in the field. He has performed more than 10,000 major surgeries. He earned his MBBS from MIMER, Pune, and completed his MS at GMC Panaji. He also completed a fellowship in Surgical Oncology at Tata Medical Centre, Kolkata, with a focus on gastrointestinal cancers.

Dr. Banswal has worked as a Co-principal Investigator in several research projects. He has published his work in both national and international journals. He is known for his patient-friendly and ethical approach. His main expertise is in Minimal Invasive Cancer Surgeries, where he consistently delivers excellent results.